Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FWYXH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,795
Award facts
- Contract value 100% obligated
- $45,795.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,795.12 delivery order to AmerisourceBergen Drug Corp for Wegovy 2.4 mg/0.75 mL pen auto-injectors on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Wegovy, a GLP-1 receptor agonist primarily used for weight management, represents part of the company's expanded pharmaceutical supply portfolio for federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's comprehensive Global Pharmaceutical Prime Vendor contract, which enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills federal orders through DLA's medical supply chain, serving customers including the Defense Health Agency and U.S. Coast Guard. The absence of a set-aside designation indicates this contract was awarded through open competition, consistent with AmerisourceBergen's demonstrated capability to meet federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWYXH?
SPE2DB25FWYXH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FWYXH worth?
The government has obligated $45,795 on SPE2DB25FWYXH.
Is contract SPE2DB25FWYXH an order under another contract?
Yes. SPE2DB25FWYXH is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWYXH competed?
The extent of competition for SPE2DB25FWYXH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award